Weekly Roundup

Eating candy is just fine for your waistline, according to a new Nutrition Journal study; PopSci helpfully points out that the research was sponsored by a candy trade group.

Canada’s National Research Council announced earlier this month that it will “refocus” away from basic research to better serve business interests and industrial applications. Those critical of this move call it short-sighted, pointing to the difficulty in projecting either the profitability or future applications of pure research.

Critics of the new edition of the DSM worry that some of its categories, including PMS and depression, are culture-bound syndromes and are not exclusively biological.

The New York Times Magazine explores research suggesting that women lose sexual interest in their monogamous male parters sooner, as well as the development of new drugs aiming to rekindle women’s sexual desire. Slate points out how this issue has been treated differently than sociobiology’s rationalizing of men’s purported hard-wired promiscuity.

What Chris Hadfield can teach us about doing PR the right way.

One Comment

  • Curtis Forbes
    Curtis Forbes Reply

    I can’t believe that they’re calling this new libido pill “female Viagra.” What a misnomer – Viagra doesn’t make anyone want to sleep with someone they didn’t want to before taking it, it just makes them able to sleep with someone that they want to (or, I guess, that they don’t want to) when their body isn’t cooperating. As far as I’m concerned, the female equivalent to Viagra is lubricant – this is some next level shit.

    Good for Slate for pointing out the hypocrisy of pathologizing women’s boredom in monogamous relationships while naturalizing men’s.

Leave a Reply

Your email address will not be published. Required fields are marked *